Journal article
A role for common genomic variants in the assessment of familial breast cancer
S Sawyer, G Mitchell, J McKinley, G Chenevix-Trench, J Beesley, XQ Chen, D Bowtell, AH Trainer, M Harris, GJ Lindeman, PA James
Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2012
Abstract
Purpose: Genome-wide association studies have identified common genomic variants associated with increased susceptibility to breast cancer. In the general population, the risk associated with these known variants seems insufficient to inform clinical management. Their contribution to the development of familial breast cancer is less clear. Patients and Methods: We studied 1,143 women with breast cancer who had completed BRCA1 and BRCA2 mutation screening as a result of a high risk for hereditary breast cancer. Genotyping of 22 breast cancer-associated genomic variants was performed. A polygenic risk score (PRS), calculated as the sum of the log odds ratios for each allele, was compared with ..
View full abstractGrants
Awarded by Victorian Cancer Agency
Awarded by U.S. Army Medical Research and Materiel Command
Funding Acknowledgements
Supported by the Victorian Cancer Agency (Grant No. CTTS07). The Australian Ovarian Cancer Study was supported by the U.S. Army Medical Research and Materiel Command under Grant No. DAMD17-01-1-0729, The Cancer Council Tasmania and The Cancer Foundation of Western Australia, and the National Health and Medical Research Council of Australia.